CLINICAL_TRIALS
trial_result
· 2020-01-09
Clinical Trial Update: A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma [Phase 2]
Summary
Phase 2 trial of PLX3397 in recurrent glioblastoma is terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo | Conditions: Recurrent Glioblastoma | Phase 2 | Status: TERMINATED | Results posted: 2020-01-09